<DOC>
	<DOCNO>NCT02195609</DOCNO>
	<brief_summary>This study aim evaluate change vasomotor symptom postmenopausal woman treat 4 month Omega-3 v Soy Isoflavones .</brief_summary>
	<brief_title>Evaluate Effect Omega-3 v Soy Isoflavones Postmenopausal Women With Moderate Severe Vasomotor Symptoms</brief_title>
	<detailed_description>This non-inferiority study Omega 3 versus Soy Isoflavones , patient control baseline . In order determine difference observe evolution intensity , frequency total number hot flash 4 month patient treat Omega-3 v Soy Isoflavones , plan include least 100 patient , 50 per treatment arm . It si estimate standar deviation 0.5 % , 10 % lose follow-up rate .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>Ambulatory complete study procedure , able read , understand sign inform consent willing come center study visit . Postmenopausal ( ≥ 1 year amenorrhea ) 6 month amenorrhea follicle stimulate hormone ( FSH ) ≥ 40 IU / L. BMI ≥ 18 kg/m2 ≤ 30 kg/m2 Flushing moderate severe intensity . Women surgical menopause . Treatment hormone replacement therapy ( HRT ) 3 month prior inclusion Uterine bleeding menopause undetermined cause 12 month prior screen . Presence history malignancy past 5 year . Malabsorption syndrome . Hype uncontrolled hypothyroidism . Dyslipidemia ( LDLcholesterol &gt; 189 mg / dl medical criterion ) require specific treatment proven effectiveness . Chronic renal disease . Uncontrolled untreated hypertension . Treatment isoflavones , tibolone , Selective Estrogen Receptors Moderators ( SERM´s ) past 3 month prior test selection period . Hormonal treatment androgen , estrogen , progestin , alone combined oral , transdermal , vaginal ( include promestriene ) implant , last 3 month prior test selection period . Patients receive require treatment antidepressant anticonvulsants Patients mental illness . History noncompliance take medication . Suspected abuse alcohol drug 12 month precede selection . Use experimental drug device within 30 day prior selection . Any condition find judgment investigator may jeopardise tral conduct accord protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Vasomotor Symptoms Associated With Menopause</keyword>
	<keyword>Menopause</keyword>
	<keyword>Hot Flashes</keyword>
	<keyword>Postmenopausal Women</keyword>
</DOC>